Brief: Atea Pharmaceuticals Q1 Basic EPS USD -0.75
14/05/2024 21:05
May 14 (Reuters) - Atea Pharmaceuticals Q1 operating expenses USD 69.806 million. * Q1 pretax profit USD -62.938 million * Q1 operating income USD -69.806 million * Q1 net income USD -63.169 million
Recent news on Atea Pharmaceuticals
See all newsAtea Pharmaceuticals Q2 loss narrows as HCV trial expenses decline
Atea Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:30 AM